INTO A LION'S DEN . . . That's where I'll be headed next Wednesday, September 7, when I participate in a panel discussion about the Vioxx litigation at the American Enterprise Institute. While not literally lions, the three other speakers are all decidedly fearsome, as well as much less pro-plaintiff than me: Jack Calfee and Ted Frank, both of AEI, and Dan Troy, former chief counsel of the FDA and currently at Sidley & Austin.
The event is titled "The $253 Million Vioxx Verdict: What Does It Mean?" The AEI website sets out the parameters of the discussion:
What implications does this verdict have for drug development, for the pharmaceutical industry, and for the justice system? What consequences will this verdict have for consumers? Is further liability reform needed, or is the current jury trial system an appropriate means of regulating drug safety?
I'll be speaking specifically on this topic: "In Defense of the Jury System, Post-Ernst." All attempts to publicize the event on other weblogs will be much appreciated. Further details can be found at AEI, Point of Law, and Overlawyered.
UPDATE . . . For all of my collected Vioxx posts, look here. If you are (a) someone who was harmed by Vioxx or (b) a lawyer who wants to refer your Vioxx cases to a highly-competent team of mass-tort lawyers, look here.